Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards

Jury Orders Talecris Biotherapeutics to Pay $37M in Contract Dispute

By Pharmaceutical Processing | December 14, 2010

Talecris Biotherapeutics Holdings Inc. announced today that a jury in the General
Court of Justice, Superior
Court Division, Wake County,
North Carolina, rendered a
verdict on December 13, 2010 in the amount of $37 million in favor of Plasma
Centers of America,
LLC, against its subsidiary, Talecris Plasma Resources, Inc., in a breach of
contract claim.

Talecris had a three-year Plasma Sale/Purchase Agreement
with Plasma Centers of America
under which Talecris was required to purchase plasma from plasma collection
centers built by Plasma Centers of America and approved by Talecris.
Under the terms of the agreement, Talecris had a conditional obligation to
purchase the centers for a sum determined by a formula set forth in the
agreement. Talecris provided approximately $4 million (excluding accrued
interest) in financing related to the development of such centers and advanced payments
for unlicensed plasma.

In August 2008, Talecris notified Plasma Centers of America
that they were in breach of a Plasma Sale/Purchase Agreement. Talecris terminated
the agreement in September 2008. In November 2008, Talecris filed suit in
federal court in Raleigh, North
Carolina against the G&M Crandall Limited Family Partnership
and its individual partners as guarantors of obligations of Plasma Centers of America.

Plasma Centers of America filed a parallel state
action in January 2009, alleging breach of contract by Talecris.

Talecris is evaluating its response to this verdict,
including appeal.

  

Related Articles Read More >

FDA logo
Ultra Supplement announces recall for undeclared tadalafil
analyzing medical sample
Expert answers to nitrosamine impurity questions
Cardinal Health
Cardinal Health announces $124M settlement of investors’ opioid suit
FDA logo
FDA warns four companies over selling honey tainted with prescription drugs

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup
Pharmaceutical Processing World
  • Subscribe to Our Free E-Newsletter
  • Contact Us
  • About Us
  • Advertise With Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index

Copyright © 2022 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • R&D 100 Awards